|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.260 USD | +2.52% |
|
+13.99% | -46.99% |
| 07-31 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.25 | 4.25 | 4.8 |
| Spread/Res. | -23.29% | -23.29% | -32.08% |
| Spread/Supp. | +13.99% | +13.99% | +13.99% |
| Support | 2.86 | 2.86 | 2.86 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
